3.32 USD
↘ 0.13 (3.77%)AT CLOSE (03:59 PM EST)
Shares of Indaptus Therapeutics, Inc. Common Stock (INDP) are trading at $3.35. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, INDP is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 17, 2026.